YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
YIHCF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $4 | $4 | $3 | $4 |
| - Cash | $1 | $2 | $2 | $4 |
| + Debt | $2 | $2 | $3 | $4 |
| Enterprise Value | $4 | $4 | $4 | $4 |
| Revenue | $1 | $2 | $3 | $3 |
| % Growth | -48.3% | -20.4% | -3.8% | – |
| Gross Profit | $1 | $2 | $2 | $3 |
| % Margin | 66.6% | 79.4% | 78.5% | 79.9% |
| EBITDA | -$8 | $9 | $1 | $2 |
| % Margin | -625.4% | 366.9% | 48.6% | 51.7% |
| Net Income | -$0 | $1 | $1 | $1 |
| % Margin | -15.9% | 27.9% | 31.2% | 32.1% |
| EPS Diluted | -0.23 | 0.78 | 1.09 | 1.17 |
| % Growth | -129.5% | -28.4% | -6.8% | – |
| Operating Cash Flow | $0 | $0 | $0 | $1 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$0 | $0 | $1 |